Like many of his colleagues in cancer research, Dr. Rafael Meza has a personal connection to cancer. His dad died from gastric cancer when Dr. Meza was 15 years old.
“That got me interested in how I could dedicate my career to cancer while my interests were in mathematics and statistics,” he said. “Eventually, I figured out that I could do research in cancer using my math skills, so I was really fortunate.”
Authors: Rebecca Towle, Christopher T. D. Dickman, Sara A. MacLellan, Jiahua Chen, Eitan Prisman, Martial Guillaud & Cathie Garnis (Garnis Lab).
You can access the full article here.
Congratulations to Dr. Shoukat Dedhar (Dedhar Lab), for being awarded $125,000 from the Cancer Research Society Charlotte Légaré Memorial Fund for his project, “Targeting Hypoxia-Driven Metabolic Effectors of Immunosuppression in Pancreatic Cancer.”
Canadian research teams, including several from BC Cancer, will receive a total of $2.4 million to advance cancer research and treatment following new awards in the 2023 Terry Fox New Frontiers Program Project Grant (PPG) competition.
Dr. Joseph Lau is working to develop the next generation of radiopharmaceuticals for both diagnostic and therapeutic purposes. Radiopharmaceuticals are radioactive compounds used in cancer care. From a diagnostic perspective, his work focusses on making these radioactive agents better able to detect and visualize cancers in the body. From a treatment perspective this helps oncologists determine if a cancer is operable, delineates margins for radiation planning or select targeted-therapies based on molecular properties of cancer.
Congratulations to Dr. Renelle Myers (Myers Lab) and team for being awarded a CCS Team Breakthrough Grant: Transforming Low-Survival Cancers for the project titled "Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) study". Dr. Myers was awarded $5.4 million over 5 years.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.